Research ArticleClinical Investigations
18F-FDG PET–Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer
Olivier Humbert, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Salim Kanoun, Inna Dygai-Cochet, Alina Berriolo-Riedinger, Michel Toubeau, Edouard Depardon, Maud Lassere, Simon Tisserand, Pierre Fumoleau, François Brunotte and Alexandre Cochet
Journal of Nuclear Medicine November 2016, 57 (11) 1707-1712; DOI: https://doi.org/10.2967/jnumed.116.172759
Olivier Humbert
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
2LE2I UMR 6306, CNRS, Arts et Métiers, Université de Bourgogne Franche-Comté, Besançon, France
Jean-Marc Riedinger
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
3Departments of Biology and Pathology, Centre GF Leclerc, Dijon, France
Jean-Marc Vrigneaud
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
2LE2I UMR 6306, CNRS, Arts et Métiers, Université de Bourgogne Franche-Comté, Besançon, France
Salim Kanoun
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
2LE2I UMR 6306, CNRS, Arts et Métiers, Université de Bourgogne Franche-Comté, Besançon, France
4Imaging Department, CHU Le Bocage, Dijon, France; and
Inna Dygai-Cochet
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
Alina Berriolo-Riedinger
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
Michel Toubeau
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
Edouard Depardon
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
Maud Lassere
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
Simon Tisserand
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
Pierre Fumoleau
5Department of Medical Oncology, Centre GF Leclerc, Dijon, France
François Brunotte
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
2LE2I UMR 6306, CNRS, Arts et Métiers, Université de Bourgogne Franche-Comté, Besançon, France
4Imaging Department, CHU Le Bocage, Dijon, France; and
Alexandre Cochet
1Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France
2LE2I UMR 6306, CNRS, Arts et Métiers, Université de Bourgogne Franche-Comté, Besançon, France
4Imaging Department, CHU Le Bocage, Dijon, France; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 11
November 1, 2016
18F-FDG PET–Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer
Olivier Humbert, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Salim Kanoun, Inna Dygai-Cochet, Alina Berriolo-Riedinger, Michel Toubeau, Edouard Depardon, Maud Lassere, Simon Tisserand, Pierre Fumoleau, François Brunotte, Alexandre Cochet
Journal of Nuclear Medicine Nov 2016, 57 (11) 1707-1712; DOI: 10.2967/jnumed.116.172759
18F-FDG PET–Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer
Olivier Humbert, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Salim Kanoun, Inna Dygai-Cochet, Alina Berriolo-Riedinger, Michel Toubeau, Edouard Depardon, Maud Lassere, Simon Tisserand, Pierre Fumoleau, François Brunotte, Alexandre Cochet
Journal of Nuclear Medicine Nov 2016, 57 (11) 1707-1712; DOI: 10.2967/jnumed.116.172759
Jump to section
Related Articles
Cited By...
- Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions
- Breast Cancer Blood Flow and Metabolism on Dual-Acquisition 18F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy Response
- 2-18F-Fluoroethanol Is a PET Reporter of Solid Tumor Perfusion
- Getting the Most out of 18F-FDG PET Scans: The Predictive Value of 18F-FDG PET-Derived Blood Flow Estimates for Breast Cancer